140 related articles for article (PubMed ID: 7466726)
1. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
[No Abstract] [Full Text] [Related]
3. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
4. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
5. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.
Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA
Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
[TBL] [Abstract][Full Text] [Related]
8. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
9. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
[No Abstract] [Full Text] [Related]
10. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
Jakasa D
Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
[No Abstract] [Full Text] [Related]
11. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
Gail MH
Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
[TBL] [Abstract][Full Text] [Related]
13. Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.
Bakker W; Nijhuis-Heddes JM; van der Velde EA
Cancer Immunol Immunother; 1986; 22(2):155-9. PubMed ID: 3719595
[TBL] [Abstract][Full Text] [Related]
14. Immune status in lung cancer: effects of BCG immunotherapy.
Gross NJ; Eddie-Quartey AC
Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of bronchial cancer with a water-saline extract of BCG].
Khadzhiev S; Kavaklieva-Dimitrova Ia
Vopr Onkol; 1971; 17(8):51-7. PubMed ID: 4943964
[No Abstract] [Full Text] [Related]
16. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
18. A stratified randomized study of intradermal BCG in patients with carcinoma of the bronchus: prolongation of quality but not length of life in inoperable patients.
Anthony HM; Madsen KE; Mason MK; Templeman GH
Cancer; 1978 Oct; 42(4):1784-92. PubMed ID: 213186
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
Taylor SG; Sisson GA; Bytell DE; Raynor WJ
Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus.
Bass GA; Furlong H; O'Sullivan KE; Hennessy TP; Walsh TN
Eur J Cancer; 2014 Apr; 50(6):1065-75. PubMed ID: 24480403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
